𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Clinical effects of monoclonal antibody 17-1A combined with granulocyte/macrophage-colony-stimulating factor and interleukin-2 for treatment of patients with advanced colorectal carcinoma

✍ Scribed by A.-L. Hjelm Skog; P. Ragnhammar; J. Fagerberg; J.-E. Frödin; M. Goldinger; H. Koldestam; M. Liljefors; B. Nilsson; J. Shetye; P. Wersäll; H. Mellstedt

Publisher
Springer-Verlag
Year
1999
Tongue
English
Weight
215 KB
Volume
48
Category
Article
ISSN
0340-7004

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase I clinical and pharmacologic stu
A phase I clinical and pharmacologic study of a carboplatin and irinotecan regimen combined with recombinant human granulocyte-colony stimulating factor in the treatment of patients with advanced nonsmall cell lung carcinoma
✍ Hiroaki Okamoto; Akira Nagatomo; Hideo Kunitoh; Hiroshi Kunikane; Koshiro Watana 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB 👁 3 views

BACKGROUND. This Phase I study was designed to determine the toxicity and efficacy of a carboplatin and irinotecan (CPT-11) regimen with recombinant human granulocyte colony-stimulating factor (rhG-CSF) support for patients with advanced nonsmall cell lung carcinoma. ## METHODS. Treatment consist

A Phase Ib/II trial of granulocyte-macro
A Phase Ib/II trial of granulocyte-macrophage−colony stimulating factor and interleukin-2 for renal cell carcinoma patients with pulmonary metastases : A case of fatal central nervous system thrombosis
✍ Kirsten M. Hotton; Masoud Khorsand; Jacquelyn A. Hank; Mark Albertini; Kyung Man 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 187 KB 👁 2 views

## BACKGROUND. Interleukin-2 (IL-2) and granulocyte-macrophageϪcolony stimulating factor (GM-CSF) are cytokines with nonoverlapping pleiotropic effects. In a prior Phase Ib study, this combination of agents exhibited antitumor effects in the lungs of four of eight patients with renal cell carcinoma